Bank of New York Mellon’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,361
| Closed | -$19.3K | – | 4251 |
|
|
2025
Q1 | $19.3K | Hold |
4,361
| – | – | ﹤0.01% | 4071 |
|
|
2024
Q4 | $30.5K | Hold |
4,361
| – | – | ﹤0.01% | 4073 |
|
|
2024
Q3 | $63.2K | Sell |
4,361
-1,507
| -26% | -$21.9K | ﹤0.01% | 4024 |
|
|
2024
Q2 | $428K | Buy |
5,868
+439
| +8% | +$32K | ﹤0.01% | 3655 |
|
|
2024
Q1 | $321K | Sell |
5,429
-144
| -3% | -$8.52K | ﹤0.01% | 3739 |
|
|
2023
Q4 | $408K | Sell |
5,573
-809
| -13% | -$59.2K | ﹤0.01% | 3664 |
|
|
2023
Q3 | $248K | Sell |
6,382
-22
| -0.3% | -$855 | ﹤0.01% | 3880 |
|
|
2023
Q2 | $369K | Buy |
6,404
+4,943
| +338% | +$285K | ﹤0.01% | 3740 |
|
|
2023
Q1 | $95K | Buy |
1,461
+311
| +27% | +$20.2K | ﹤0.01% | 4080 |
|
|
2022
Q4 | $31.6K | Sell |
1,150
-6
| -0.5% | -$165 | ﹤0.01% | 4296 |
|
|
2022
Q3 | $34K | Hold |
1,156
| – | – | ﹤0.01% | 4380 |
|
|
2022
Q2 | $22K | Sell |
1,156
-3,425
| -75% | -$65.2K | ﹤0.01% | 4482 |
|
|
2022
Q1 | $372K | Sell |
4,581
-12
| -0.3% | -$974 | ﹤0.01% | 3889 |
|
|
2021
Q4 | $420K | Buy |
4,593
+73
| +2% | +$6.68K | ﹤0.01% | 3908 |
|
|
2021
Q3 | $565K | Buy |
4,520
+300
| +7% | +$37.5K | ﹤0.01% | 3740 |
|
|
2021
Q2 | $476K | Sell |
4,220
-185
| -4% | -$20.9K | ﹤0.01% | 3791 |
|
|
2021
Q1 | $667K | Sell |
4,405
-674
| -13% | -$102K | ﹤0.01% | 3533 |
|
|
2020
Q4 | $584K | Buy |
5,079
+1,881
| +59% | +$216K | ﹤0.01% | 3540 |
|
|
2020
Q3 | $247K | Sell |
3,198
-85
| -3% | -$6.57K | ﹤0.01% | 3777 |
|
|
2020
Q2 | $362K | Sell |
3,283
-291
| -8% | -$32.1K | ﹤0.01% | 3625 |
|
|
2020
Q1 | $391K | Hold |
3,574
| – | – | ﹤0.01% | 3486 |
|
|
2019
Q4 | $568K | Buy |
3,574
+8
| +0.2% | +$1.27K | ﹤0.01% | 3529 |
|
|
2019
Q3 | $526K | Sell |
3,566
-195
| -5% | -$28.8K | ﹤0.01% | 3506 |
|
|
2019
Q2 | $437K | Buy |
3,761
+1,220
| +48% | +$142K | ﹤0.01% | 3663 |
|
|
2019
Q1 | $275K | Buy |
2,541
+875
| +53% | +$94.7K | ﹤0.01% | 3767 |
|
|
2018
Q4 | $136K | Buy |
1,666
+468
| +39% | +$38.2K | ﹤0.01% | 3916 |
|
|
2018
Q3 | $195K | Buy |
+1,198
| New | +$195K | ﹤0.01% | 3931 |
|